UbiQ Bio BV:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:UbiQ Bio BV - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11225
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
UbiQ Bio BV (UbiQ) is a biotechnology company that develops and commercializes ubiquitinated peptides and assays that enables drug discovery in Ubiquitin field. The company provides products such as ubiquitin-proteasome system, high throughput screening assay reagents and ubiquitinated polypeptides. It products are used in accelerate drug discovery, target identification and validation, hit-to-lead discovery, lead on target validation and optimization, and other applications. The company’s technology platform consists of UbiQ-Block, UbiQ-Click, and UbiQ-Syn that are used to develop products and services in the ubiquitin field. UbiQ is headquartered in Amsterdam, the Netherlands.

UbiQ Bio BV – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
UbiQ Bio BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
UbiQ Bio BV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
UbiQ Bio BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
UbiQ Bio BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
UbiQ Bio BV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
UbiQ Bio BV, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Mercachem Forms Joint Venture with UbiQ Bio 10
Ubiquigent Enters into Co-Development Agreement with UbiQ 11
Avacta Enters Into Agreement With UbiQ Bio For Ubiquitin Affimers 12
UbiQ Partners with Neuroscience 13
UbiQ Bio BV – Key Competitors 14
UbiQ Bio BV – Key Employees 15
UbiQ Bio BV – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Joint Venture 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
UbiQ Bio BV, Pharmaceuticals & Healthcare, Key Facts 2
UbiQ Bio BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
UbiQ Bio BV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
UbiQ Bio BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
UbiQ Bio BV, Deals By Therapy Area, 2012 to YTD 2018 8
UbiQ Bio BV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Mercachem Forms Joint Venture with UbiQ Bio 10
Ubiquigent Enters into Co-Development Agreement with UbiQ 11
Avacta Enters Into Agreement With UbiQ Bio For Ubiquitin Affimers 12
UbiQ Partners with Neuroscience 13
UbiQ Bio BV, Key Competitors 14
UbiQ Bio BV, Key Employees 15
UbiQ Bio BV, Joint Venture 16

List of Figures
UbiQ Bio BV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
UbiQ Bio BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
UbiQ Bio BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
UbiQ Bio BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
UbiQ Bio BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
UbiQ Bio BV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
UbiQ Bio BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
UbiQ Bio BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[UbiQ Bio BV:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Saudi Aramco:企業の戦略・SWOT・財務情報
    Saudi Aramco - Strategy, SWOT and Corporate Finance Report Summary Saudi Aramco - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Cargill, Incorporated:企業のM&A・事業提携・投資動向
    Cargill, Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cargill, Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • CVR Energy, Inc.:企業の戦略・SWOT・財務情報
    CVR Energy, Inc. - Strategy, SWOT and Corporate Finance Report Summary CVR Energy, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Neptune Orient Lines Limited:企業の戦略・SWOT・財務情報
    Neptune Orient Lines Limited - Strategy, SWOT and Corporate Finance Report Summary Neptune Orient Lines Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • MolecularMD Corp:医療機器:M&Aディール及び事業提携情報
    Summary MolecularMD Corp (MMD) is a diagnostics solution provider that develops and commercialize molecular diagnostic tests, which are deployed and leveraged across the continuum of the drug development process. The company offers assay design and development services, sample banking and bridging s …
  • Netsmart Technologies Inc-医療機器分野:企業M&A・提携分析
    Summary Netsmart Technologies Inc (Netsmart) is a subsidiary of GI Partner, is a provider of enterprise software solutions for health and human services providers and payers. It provides on-demand and on-premise software solutions to automate major financial, clinical and management processes to its …
  • Invesco Ltd:戦略・SWOT・企業財務分析
    Invesco Ltd - Strategy, SWOT and Corporate Finance Report Summary Invesco Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Curtiss-Wright Corporation (CW)-エネルギー分野:企業M&A・提携分析
    Summary Curtiss-Wright Corporation (Curtiss-Wright) is a diversified industrial company. It designs, manufactures and overhauls precision components and provides highly engineered and critical-function products, systems and services. Its offerings include sensor handling systems, surface technology …
  • Genting Bhd (GENTING):企業の財務・戦略的SWOT分析
    Genting Bhd (GENTING) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Conn’S, Inc.:企業の戦略・SWOT・財務分析
    Conn'S, Inc. - Strategy, SWOT and Corporate Finance Report Summary Conn'S, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Phillips 66 (PSX):企業の財務・戦略的SWOT分析
    Phillips 66 (PSX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Sangamo Therapeutics Inc (SGMO):製薬・医療:M&Aディール及び事業提携情報
    Summary Sangamo Therapeutics Inc (Sangamo), formerly Sangamo BioSciences Inc, is a clinical stage biotechnology company that focuses on the research, development and commercialization of engineered DNA-binding proteins (ZFPs) for gene regulation, cell therapy and therapeutic genome editing. Its prod …
  • Electricidade de Mocambique EP:電力:M&Aディール及び事業提携情報
    Summary Electricidade de Mocambique EP (EDM) is a state owned vertically integrated energy utility that generates, distributes, transmits, and commercializes electricity. It produces electricity from hydro and thermal sources. The company has interests in Lichinga, Cuamba, Corumana, Chicamba, and Ma …
  • Sebia SA:製品パイプライン分析
    Summary Sebia SA (Sebia) is a medical device company that designs, manufactures, commercializes, and exports electrophoresis tests and analyzers for diagnosis of cancer. The company's electrophoresis program offer automated system for capillary electrophoresis, gel electrophoresis and electrophoresi …
  • Oxford BioTherapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Oxford BioTherapeutics Ltd (OBT) is a clinical stage oncology company that develops antibody drug conjugates for the treatment of variety of cancers. The company’s product pipelines currently includes T-cell based IO therapies including check point modulators; NK cell based IO therapies such …
  • Redhall Group Plc:企業の戦略・SWOT・財務情報
    Redhall Group Plc - Strategy, SWOT and Corporate Finance Report Summary Redhall Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Columbia University-製薬・医療分野:企業M&A・提携分析
    Summary Columbia University (CU) is an educational service provider that offers educational and research programs. The university provides educational services and courses through its schools, departments, faculties, centers and institutes. It provides undergraduate and graduate courses in various d …
  • Alimera Sciences Inc (ALIM):医療機器:M&Aディール及び事業提携情報
    Summary Alimera Sciences Inc (Alimera) is a biopharmaceutical company that researches, develops and commercializes prescription ophthalmic pharmaceuticals. The company’s products include Iluvien, an intravitreal implant of fluocinolone acetonide which is indicated for the treatment of chronic diabet …
  • BoneSupport AB:企業の戦略的SWOT分析
    BoneSupport AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Sangetsu Corporation (8130):企業の財務・戦略的SWOT分析
    Sangetsu Corporation (8130) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆